Jennifer Finch, the bassist and co-founder of the influential punk band L7, has died after being diagnosed with an aggressive form of brain cancer. According to a report from USA Today, Finch was diagnosed with glioblastoma, a fast-growing and malignant brain tumor. The news brings attention to a disease that remains difficult to treat and often has a poor prognosis.

Key takeaways about glioblastoma and the news

  • Jennifer Finch died from glioblastoma, an aggressive brain cancer that affects the brain’s glial cells.
  • Glioblastoma is the most common and most aggressive primary brain tumor in adults.
  • Standard treatment includes surgery, radiation, and chemotherapy, but the cancer often recurs.
  • The median survival time is about 12 to 15 months with treatment.
  • Finch’s diagnosis and death underscore the urgent need for better therapies for this disease.

What is glioblastoma?

Glioblastoma is a type of cancer that starts in the brain’s glial cells, which support nerve cells. It is classified as a grade IV astrocytoma, meaning it is highly malignant and grows quickly. The tumor can spread within the brain but rarely spreads to other parts of the body. Glioblastoma is the most common primary brain tumor in adults, with about 12,000 to 15,000 new cases diagnosed each year in the United States, according to the American Brain Tumor Association.

Symptoms and signs

Because glioblastoma grows rapidly, symptoms often appear suddenly. Common signs include persistent headaches, seizures, nausea, vomiting, and changes in personality or cognitive function. Other symptoms may include weakness on one side of the body, difficulty speaking, or vision problems. The specific symptoms depend on the location of the tumor in the brain. Many people first see a doctor after experiencing a seizure or a severe headache that does not go away.

Risk factors

The exact cause of glioblastoma is not known, and most cases occur in people with no clear risk factors. However, a few factors have been linked to a higher chance of developing the disease. These include exposure to high doses of ionizing radiation, such as from radiation therapy for other cancers. Genetic conditions like neurofibromatosis type 1 and Li-Fraumeni syndrome also increase risk. Age is another factor; glioblastoma is more common in older adults, with the average age at diagnosis being about 64 years.

Treatment options

Treatment for glioblastoma typically involves a combination of surgery, radiation therapy, and chemotherapy. The first step is often surgical removal of as much of the tumor as possible, called maximal safe resection. After surgery, patients usually receive radiation therapy to kill remaining cancer cells, along with the chemotherapy drug temozolomide. This regimen is known as the Stupp protocol and has been the standard of care since 2005. Despite aggressive treatment, glioblastoma almost always recurs, and additional therapies such as targeted drugs or immunotherapy may be used in clinical trials.

Prognosis and outlook

The prognosis for glioblastoma remains poor. Even with standard treatment, the median survival time is about 12 to 15 months, and only about 5% to 10% of patients live longer than five years. The tumor’s ability to infiltrate healthy brain tissue makes complete removal nearly impossible, and it often develops resistance to chemotherapy. Research continues into new treatments, including immunotherapy, tumor treating fields, and personalized medicine, but progress has been slow.

Frequently Asked Questions

What is the difference between glioblastoma and other brain tumors?

Glioblastoma is a grade IV astrocytoma, meaning it is the most aggressive type of glioma. Other brain tumors, such as meningiomas, are often benign and grow slowly, while glioblastoma grows rapidly and invades surrounding brain tissue. It is also more likely to recur after treatment compared to lower-grade tumors.

Can glioblastoma be prevented?

There is no known way to prevent glioblastoma. Most cases occur in people without any identifiable risk factors. Avoiding unnecessary exposure to ionizing radiation may reduce the risk, but this is a rare cause. Genetic counseling may be recommended for those with a family history of certain genetic syndromes linked to brain tumors.

How is glioblastoma diagnosed?

Diagnosis typically begins with a neurological exam and imaging tests such as an MRI or CT scan. If a tumor is found, a neurosurgeon will perform a biopsy to remove a small sample of tissue for examination under a microscope. Genetic testing of the tumor may also be done to look for markers like MGMT methylation, which can help guide treatment decisions.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.